GPhA Hires Felecia Tan, Associate Vice President for Sciences and Regulatory Affairs
WASHINGTON, DC (May 5, 2014) — The Generic Pharmaceutical Association (GPhA) today announced the hiring of Felecia (Lisa) Tan, Associate Vice President for Sciences and Regulatory Affairs. Tan is a former practicing pharmacist who brings more than 25 years of healthcare industry and Food and Drug Administration (FDA) experience to GPhA.
“We are delighted that Lisa Tan has joined the GPhA staff. Her hiring demonstrates our continued commitment to making collaboration with FDA a key priority,” said Ralph G. Neas, GPhA President and CEO. “Lisa’s private sector background and her extensive experience at FDA, particularly in the Office of Pharmaceutical Sciences (OPS) and the Office of Generic Drugs (OGD), will help make the generic drug industry an even stronger partner with FDA in the future. Lisa’s mastery of the abbreviated new drug approval regulatory framework will be invaluable in the association’s efforts to work with FDA to enhance the ANDA process and support the full application of the Generic Drug User Fee Act (GDUFA).”
Among the many qualifications Lisa brings to GPhA are pharmacy operations management and leadership experience, specialized expertise in pharmaceutical science, and nuanced understanding of the highly technical federal regulatory process for generic drugs.
At the FDA Center for Drug Evaluation and Research’s (CDER) OPS and OGD, Lisa was responsible for streamlining and improving filing processes and protocol, receiving multiple awards for operations leadership and technical expertise in bioequivalence and paragraph IV filings.
Prior to joining FDA, Lisa held several pharmacy operations management positions. She earned a pharmacy degree from the Massachusetts College of Pharmacy.
GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 84 percent of the prescriptions dispensed in the U.S. but consume just 27 percent of the total drug spending. Additional information is available at www.gphaonline.org. Follow us on twitter: @gpha.